Skip to content

Amphastar Pharmaceuticals AMPH Goodwill and Intangible Assets, Net

Goodwill and Intangible Assets, Net at other companies

Cardinal Health logo
Cardinal HealthCAH

Other financials

Income statement

See full
Revenue$171.2M+0.4%
Gross profit$70.3M-17.5%
Operating income$13.6M-63.5%
Net income$6.4M-74.6%
EPS (diluted)$0.14-72.5%

Balance sheet

See full
Cash & equivalents$170.9M-6.5%
Total debt$686.6M+5.2%
Total equity$445.5M
Total assets$1.6B+1.3%

Cash flow

See full
Operating cash flow$47.8M+36.4%
CapEx$9.5M-11.1%
Free cash flow$38.3M+57.2%

Valuation

See full
Market cap$927.72M-19.9%
Enterprise value$1.44B-11.3%
P/E11.7×+3.5×
P/S1.3×-0.3×

Profitability

See full
Gross margin47.3%-3.2pp
Operating margin16.2%-10.4pp
Net margin11%-8.4pp
FCF margin18.8%-1.8pp

Returns & leverage

See full
Return on equity14.7%
Debt / equity0.2×
Current ratio3.9×+0.9×

Where this comes from

Reported directly by Amphastar Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IntangibleAssetsNetIncludingGoodwill.

The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amphastar Pharmaceuticals's goodwill and intangible assets, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amphastar Pharmaceuticals's goodwill and intangible assets, net?
Amphastar Pharmaceuticals (AMPH) reported goodwill and intangible assets, net of $559.62M in Q1 2026.
How has Amphastar Pharmaceuticals's goodwill and intangible assets, net changed year-over-year?
Amphastar Pharmaceuticals's goodwill and intangible assets, net decreased by 4.3% year-over-year, from $584.53M to $559.62M.
What is the long-term trend for Amphastar Pharmaceuticals's goodwill and intangible assets, net?
Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's goodwill and intangible assets, net has grown at a 69.4% compound annual growth rate (CAGR), from $40.62M to $565.97M.